|
Apr 24
|
Roche Q1 sales up 7% on drugs Phesgo, Vabysmo
|
|
Apr 24
|
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter
|
|
Apr 23
|
Roche looks to a Flagship startup in search of new immune drugs
|
|
Apr 23
|
Switzerland flexes financial muscle ahead of tariff date in Washington
|
|
Apr 23
|
Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)
|
|
Apr 22
|
Roche says it will invest $50 billion in the U.S. as tariff fears hit pharma
|
|
Apr 22
|
Swiss Pharma Giant Roche To Invest $50B in US Amid Tariff Threat
|
|
Apr 22
|
Roche, answering tariff threat, pledges $50B to US drug production
|
|
Apr 22
|
Pharma giant plots US weight-loss drug factory
|
|
Apr 22
|
Morning Bid:'Major loser' reporting for duty
|
|
Apr 22
|
Drug Companies Step Up 'Make in America' Plans to Counter Tariffs
|
|
Apr 22
|
Swiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.
|
|
Apr 18
|
Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever
|
|
Apr 17
|
Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback
|
|
Apr 14
|
Roche Gets Nod for Expanded Use of Columvi in Lymphoma in Europe
|
|
Apr 14
|
Roche’s Columvi combo gains EC approval for DLBCL
|
|
Apr 14
|
European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy
|
|
Mar 14
|
The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J
|
|
Mar 14
|
Roche Diagnostics supports UK eye cancer AI initiative
|
|
Mar 14
|
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter
|